Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate.
The role of dynorphin-(1-13) and dynorphin-(1-10)-amide in the neuroendocrine control of primate anterior pituitary hormones was studied in nonrestrained, ovariectomized rhesus monkeys. The effects of these opioids on plasma concentrations of prolactin (PRL), luteinizing hormone (LH), follicle stimulating hormone (FSH) and thyrotropin (TSH), and interactions with naloxone are reported here. Intravenous administration of dynorphin-(1-13), 30 to 120 micrograms/kg, significantly increased plasma PRL levels 3- to 4-fold. These PRL increases occurred within 5 min and levels remained elevated for at least 60 min. Administration of naloxone (1.0 mg/kg i.v.) antagonized the rise in PRL levels. Dynorphin-(1-13) had no significant effect on plasma LH, FSH or TSH levels. Dynorphin-(1-10)-amide (30-120 micrograms/kg) increased plasma PRL levels 2- to 4-fold at 5 to 40 min after administration. Plasma LH levels were significantly depressed 100 to 120 min postdrug. Dynorphin-(1-10)-amide produced no change in plasma FSH or TSH levels. These results indicate that dynorphin is involved in the modulation of PRL and perhaps LH secretion, although not affecting TSH or FSH release.
D000818:Animals; D004399:Dynorphins / Q000494:pharmacology*; D005260:Female; D008253:Macaca mulatta; D009270:Naloxone / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010908:Pituitary Hormones, Anterior / Q000097:blood*; D011957:Receptors, Opioid / Q000187:drug effects; D013972:Thyrotropin / Q000097:blood
D010446:Peptide Fragments; D010908:Pituitary Hormones, Anterior; D011957:Receptors, Opioid; D009270:Naloxone; C026843:dynorphin (1-13); D004399:Dynorphins; C039666:dynorphin amide (1-10); D013972:Thyrotropin